FDMT vs STE · rev $37.0K vs P/E 25, rev $5.46B
4D Molecular Therapeutics Inc (FDMT) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
FDMT currently screens at market cap $518.1M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the FDMT and STE stock pages for the full models.
Not investment advice.